Postpartum medical rehabilitation of obese women

Makarova E.L., Olina A.A.

1) City Perinatal Center, M.A. Tverye City Hospital, Perm, Russia; 2) D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology, Saint Petersburg, Russia; 3) Academician Ye.A. Vagner Perm State Medical University, Perm, Russia
The postpartum period is limited to 42 days, while the rehabilitation of a woman takes an average of 1 year. When implementing reproductive plans, obese women often face the worsening course of somatic disease and the development of a number of new diseases.
Objective. To determine the effectiveness of a comprehensive postpartum rehabilitation program implemented for 12 months in obese women.
Subjects and methods. The investigation enrolled 64 puerperas, of whom 33 were diagnosed with obesity and used a postpartum rehabilitation program. A comprehensive rehabilitation program was proposed to be used for 60 months postpartum, which included lifestyle modifications (proper nutrition, sufficient physical activity), cholecalciferol supplementation with at least 1500 IU to replenish vitamin D levels, medical correction of obesity with the combined drug Reduxin Forte for 3 months (after stopping breastfeeding), and consultations with a psychotherapist.
Results. The women lost weight (by an average of 7.68 kg), improved their psychological status (there was no risk of postpartum depression; the manifestations of maternal melancholy were minimized), and every two (48.5%) patients reached the standard serum vitamin D levels. The rehabilitation program could improve the puerperas’ somatic health: the detection of non-alcoholic fatty liver disease was twice as common; there were no cases of diabetes mellitus.
Conclusion. The proposed postpartum rehabilitation program has a positive impact on the body, by improving the physical, mental, somatic, and sexual health of a woman, which generally indicates a change in her quality of life.

Keywords

postpartum period
rehabilitation
obesity
sibutramine
metformin
cholecalciferol
postpartum depression
sexual function index

References

  1. Ng M., Fleming T., Robinson M., Thomson B., Graetz N., Margono C. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384(9945): 766-81. https://dx.doi.org/10.1016/S0140-6736(14)60460-8.
  2. Jungheim E.S., Travieso J.L., Carson K.R., Moley K.H. Obesity and reproductive function. Obstet. Gynecol. Clin. North Am. 2012; 39(4): 479-93. https://dx.doi.org/10.1016/j.ogc.2012.09.002.
  3. Stefan N., Häring H.-U., Hu F.B., Schulze M.B. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013; 1(2): 152-62. https://dx.doi.org/10.1016/S2213-8587(13)70062-7.
  4. Bell J.A., Kivimaki M., Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta‐analysis of prospective cohort studies. Obes. Rev. 2014; 15(6): 504-15. https://dx.doi.org/10.1111/obr.12157.
  5. Nguyen T., Lau D.C.W. The obesity epidemic and its impact on hypertension. Can. J. Cardiol. 2012; 28(3): 326-33. https://dx.doi.org/10.1016/j.cjca.2012.01.001.
  6. Mihalko W.M., Bergin P.F., Kelly F.B., Canale S.T. Obesity, orthopaedics, and outcomes. J. Am. Acad. Orthop. Surg. 2014; 22(11): 683-90. https://dx.doi.org/10.5435/JAAOS-22-11-683.
  7. Rennie K.L., Jebb S.A. Prevalence of obesity in Great Britain. Obes. Rev. 2005; 6(1): 11-2. https://dx.doi.org/10.1111/j.1467-789X.2005.00164.x.
  8. Макарова Е.Л., Олина А.А., Терехина Н.А. Роль комплексной программы прегравидарной подготовки женщин с ожирением в профилактике гестационных осложнений. Акушерство и гинекология. 2020; 4: 182-8. [Makarova E.L., Olina A.A., Terekhina N.A. Role of a comprehensive pregravid preparation program for obese women in the prevention of gestational complications. Obstetrics and Gynecology. 2020; 4: 182-8. (in Russian)]. https://dx.doi.org/10.18565/aig.2020.4.182-188.
  9. Макарова Е.Л., Падруль М.М. Ожирение и гиповитаминоз D, как фактор риска послеродовых осложнений. Пермский медицинский журнал. 2019; 36(5): 5-10. [Makarova E.L., Padrul M.M. Obesity and hypovitaminosis D as a risk factor for postpartum complications. Perm Medical Journal. 2019; 36(5): 5-10. (in Russian)].
  10. Rosenblum O., Danon G., Nestour A. Les depressions maternelles postnatales: description, psychopathologie et aspects therapeutiques. Perspect. Psychiatr. 2000; 39(3): 185-98.
  11. Rosen R.S., Brown C., Heiman J., Leiblum S.R., Meston C., Shabsigh R. et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J. Sex Marital Ther. 2000; 26(2): 191-208. https://dx.doi.org/10.1080/009262300278597.
  12. Loria P., Adinolfi L.E., Bellentani S., Bugianesi E., Grieco A., Fargion S. et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A Decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig. Liv. Dis. 2010; 42(4): 272-82. https://dx.doi.org/10.1016/j.dld.2010.01.021.
  13. Громова О.А., Торшин И.Ю. Витамин D – смена парадигмы. М.: ГЭОТАР-Медиа; 2017. 568с. [Gromova O.A., Torshin I.Yu. Vitamin D – paradigm shift. Moscow: GEOTAR-Media; 2017. 568p.(in Russian)].
  14. Клинический протокол «Гипертензивные расстройства во время беременности, в родах, в послеродовом периоде. Преэклампсия, Эклампсия». М.; 2014. [Clinical protocol “Hypertensive disorders during pregnancy, childbirth, and the postpartum period. Preeclampsia, Eclampsia”. Moscow; 2014. (in Russian)].
  15. Maxwell C., Gaudet L., Cassir G., Nowik C., McLeod N.L., Jacob C.É., Walker M. Guideline No 392 – pregnancy and maternal obesity Part 2: Team planning for delivery and postpartum care. J. Obstet. Gynaecol. Can. 2019; 41(11): 1660-75. https://dx.doi.org/10.1016/j.jogc.2019.03.027.
  16. Диагностика, лечение, профилактика ожирения и ассоциированных с ним заболеваний. Национальные клинические рекомендации. СПб.; 2017: 7-10. [Diagnosis, treatment, prevention of obesity and associated diseases. National clinical guidelines. 2017; 7-10. (in Russian)].
  17. Учамприна В.А., Романцова Т.И., Калашникова М.Ф. Комплексный подход в лечении метаболического синдрома. Ожирение и метаболизм. 2014; 1: 32-7. [Uchamprina V.A., Romantsova T.I., Kalashnikova M.F. An integrated approach to the treatment of metabolic syndrome. Obesity and metabolism. 2014; 1: 32-7. (in Russian)].
  18. Мельниченко Г.А., Романцова Т.И., Журавлева М.В. Всероссийская программа безопасного снижения веса «ПримаВера». Итоги первого года проведения. Ожирение и метаболизм. 2014; 1: 62-7. [Melnichenko G.A., Romantsova T.I., Zhuravleva M.V. All-Russian program of safe weight loss „PrimaVera”. Results of the first year of the event. Obesity and metabolism. 2014; 1: 62-7. (in Russian)].
  19. Ryan D.H., Yockey S.R. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr. Obes. Rep. 2017; 6(2): 187-94. https://dx.doi.org/10.1007/s13679-017-0262-y.

Received 29.12.2020

Accepted 13.01.2021

About the Authors

Elena L. Makarova, Cand. Med. Sci., obstetrician/gynecologist, City Perinatal Center, M.A. Tverie City Hospital. Tел. +7(904)849-37-70.E-mail: makarova_803@mail.ru. ORCID: 0000-0002-1330-8341; Scopus ID: 278641.
2, Brothers Ignatyev str., Perm, 614600, Russia.
Anna A. Olina, Dr. Med. Sci., Professor, First Deputy Director, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology; Academician Ye.A. Vagner
Perm State Medical University. Tel.: +7(922)329-53-62. E-mail: olina29@mail.ru. ORCID: 0000-0001-9101-7569; Scopus ID: 56021173500.
3, Mendeleevskaya Line, Saint Petersburg, 199034, Russia.

For citation: Makarova E.L., Olina A.A. Postpartum medical rehabilitation of obese women.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2021; 1: 147-154 (in Russian)
https://dx.doi.org/10.18565/aig.2021.1.147-154

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.